Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Magid

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
Journal of the National Cancer Institute|September 6, 2012
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort studyErin J Aiello Bowles, Robert Wellman, Heather Spencer Feigelson, et al.
Journal of General Internal Medicine|January 21, 2006
Laboratory monitoring of drugs at initiation of therapy in ambulatory careMarsha A Raebel, Ella E Lyons, Susan E Andrade, et al.
Pediatrics|July 4, 2013
Patterns of care and persistence after incident elevated blood pressureMatthew F Daley, Alan R Sinaiko, Liza M Reifler, et al.
Circulation|October 21, 2020
Part 7: Systems of Care: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular CareKatherine M Berg, Adam Cheng, Ashish R Panchal, et al.
Heart (British Cardiac Society)|October 16, 2016
Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillatorsNisha Bansal, Adam Szpiro, Frederick Masoudi, et al.
Journal of the American Heart Association|June 4, 2015
Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research NetworkFrederick A Masoudi, Alan S Go, David J Magid, et al.
JAMA|December 2, 2024
Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: A Randomized Pragmatic TrialP Michael Ho, Thomas J Glorioso, Larry A Allen, et al.
American Heart Journal|September 1, 2020
An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trialGrace E Venechuk, Prateeti Khazanie, Robert L Page, et al.
The American Journal of Medicine|July 15, 2015
Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort StudyDavid H Smith, Eric S Johnson, Denise M Boudreau, et al.
Journal of the American Heart Association|November 11, 2017
Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-DefibrillatorsPamela N Peterson, Robert T Greenlee, Alan S Go, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Journal of the National Cancer Institute|September 6, 2012
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort studyErin J Aiello Bowles, Robert Wellman, Heather Spencer Feigelson, et al.
Journal of General Internal Medicine|January 21, 2006
Laboratory monitoring of drugs at initiation of therapy in ambulatory careMarsha A Raebel, Ella E Lyons, Susan E Andrade, et al.
Pediatrics|July 4, 2013
Patterns of care and persistence after incident elevated blood pressureMatthew F Daley, Alan R Sinaiko, Liza M Reifler, et al.
Circulation|October 21, 2020
Part 7: Systems of Care: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular CareKatherine M Berg, Adam Cheng, Ashish R Panchal, et al.
Heart (British Cardiac Society)|October 16, 2016
Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillatorsNisha Bansal, Adam Szpiro, Frederick Masoudi, et al.
Journal of the American Heart Association|June 4, 2015
Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research NetworkFrederick A Masoudi, Alan S Go, David J Magid, et al.
JAMA|December 2, 2024
Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: A Randomized Pragmatic TrialP Michael Ho, Thomas J Glorioso, Larry A Allen, et al.
American Heart Journal|September 1, 2020
An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trialGrace E Venechuk, Prateeti Khazanie, Robert L Page, et al.
The American Journal of Medicine|July 15, 2015
Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort StudyDavid H Smith, Eric S Johnson, Denise M Boudreau, et al.
Journal of the American Heart Association|November 11, 2017
Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-DefibrillatorsPamela N Peterson, Robert T Greenlee, Alan S Go, et al.
Pageof 19